-

FORM 38.5(b)- Osmotica Pharmaceuticals plc - AMENDMENT

LONDON--(BUSINESS WIRE)-- 

Ap27

FORM 38.5(b) - Amendment to Purchase

IRISH TAKEOVER PANEL

DISCLOSURE UNDER RULE 38.5(b) OF THE IRISH TAKEOVER PANEL ACT, 1997, TAKEOVER RULES, 2013

DEALINGS BY CONNECTED EXEMPT PRINCIPAL TRADERS WITHOUT RECOGNISED INTERMEDIARY STATUS, OR WITH RECOGNISED INTERMEDIARY STATUS BUT NOT DEALING IN A CLIENT-SERVING CAPACITY

1. KEY INFORMATION

Name of exempt principal trader:

BARCLAYS CAPITAL INC

Company dealt in

OSMOTICA PHARMACEUTICALS PLC

Class of relevant security to which the 

US$0.01 ordinary shares

dealings being disclosed relate 
Date of dealing

18 December 2020

2. INTERESTS AND SHORT POSITIONS

a. Interests and short positions (following dealing) in the class of relevant security dealt in (Note 2)

Class of relevant security: ORD    
 

Interests

Short Positions

 

Number

(%)

Number

(%)

(1)

Relevant securities owned

 

 

 

 

 

320

0.00%

5,635

0.01%

   

 

 

 

 

(2)

Derivatives (other than options):

 

 

 

 

 

0

0.00%

0

0.00%

   

 

 

 

 

(3)

Options and agreements to

 

 

 

 

purchase/sell:

0

0.00%

0

0.00%

 

 

 

 

 

 

 

 

 

 

TOTAL:

320

0.00%

5,635

0.01%

 

 

 

 

b. Interests and short positions in relevant securities of the company, otherthan the class dealt in (Note 2)

Class of relevant security:

Long

Short

 

Number

 

(%)

Number

 

(%)

(1) Relevant securities

 

 

(2) Derivatives (other than options)

 

 

(3) Options and agreements to purchase/sell

 

 

Total

 

 

 

Ap28

3. DEALINGS (Note 3)

a. Purchases and sales

Purchase/sale

Number of

Price per unit

 

securities

 

Purchase

100

5.7600   USD

Purchase

100

5.7500   USD

Purchase

140

5.7464   USD

Purchase

200

5.7750   USD

Purchase

427

5.7200   USD

Purchase

500

5.8280   USD

Purchase

6,054

5.8778   USD

Sale

5,719

5.7200   USD

Sale

7,094

5.8653   USD

b. Derivatives transactions (other than options transactions)

Product name,

e.g. CFD

Nature of transaction

(Note 5)

Number of relevant securities

(Note 6)

Price per unit

(Note 4)

 

 

 

 

i. Options transactions in respect of existing relevant securities

ii. Writing, selling, purchasingor varying

Product name,

e.g. call option

Writing, selling, purchasing, varying etc.

Number of securities to which the option relates (Note 7)

Exercise price

Type, e.g. American, European etc.

Expiry date

Option money paid/received per unit (Note 4)

 

 

 

 

 

 

 

c. Exercising

Product name,

e.g. call option

Number of securities

Exercise price per unit (Note 4)

 

 

 

d. Other dealings (including transactions in respect of new securities) (Note 3)

Nature of transaction

(Note 7)

Details

Price per unit

(if applicable) (Note 4)

 

 

 

 

Ap29

4. OTHER INFORMATION

Agreements, arrangements or understandings relating to options or derivatives

Full details of any agreement, arrangement or understanding between the person disclosing and any other person relating to the voting rights of any relevant securities under any option referred to on this form or relating to the voting rights or future acquisition or disposal of any relevant securities to which any derivative referred to on this form is referenced. If none, this should be stated.

None

Is a Supplemental Form 38.5(b) attached?  NO
Date of disclosure:

24 Dec 2020

Contact name:

Large Holdings Regulatory Operations

Telephone number:

020 3134 7213

Name of offeree/offeror with which connected

 

Nature of connection  

 

Contacts

BARCLAYS PLC

BARCLAYS PLC

LSE:BARC

Release Versions

Contacts

BARCLAYS PLC

More News From BARCLAYS PLC

BARCLAYS PLC UK Regulatory Announcement: Form 8.3 - STAGECOACH GROUP PLC

LONDON--(BUSINESS WIRE)--  FORM 8.3 PUBLIC OPENING POSITION DISCLOSURE/DEALING DISCLOSURE BY A PERSON WITH INTERESTS IN RELEVANT SECURITIES REPRESENTING 1% OR MORE Rule 8.3 of the Takeover Code (the “Code”) 1. KEY INFORMATION (a) Full name of discloser: Barclays PLC. (b) Owner or controller of interests and short positions disclosed, if different from 1(a): The naming of nominee or vehicle companies is insufficient. For a trust, the trustee(s), settlor and beneficiaries must be named.   (c) Nam...

BARCLAYS PLC UK Regulatory Announcement: FORM 8.3 - ULTRA ELECTRONICS HOLDINGS PLC

LONDON--(BUSINESS WIRE)--  FORM 8.3 PUBLIC OPENING POSITION DISCLOSURE/DEALING DISCLOSURE BY A PERSON WITH INTERESTS IN RELEVANT SECURITIES REPRESENTING 1% OR MORE Rule 8.3 of the Takeover Code (the “Code”) 1. KEY INFORMATION (a) Full name of discloser: Barclays PLC. (b) Owner or controller of interests and short positions disclosed, if different from 1(a): The naming of nominee or vehicle companies is insufficient. For a trust, the trustee(s), settlor and beneficiaries must be named.   (c) Nam...

BARCLAYS PLC UK Regulatory Announcement: FORM 8.3 - VIVO ENERGY PLC

LONDON--(BUSINESS WIRE)--  FORM 8.3 PUBLIC OPENING POSITION DISCLOSURE/DEALING DISCLOSURE BY A PERSON WITH INTERESTS IN RELEVANT SECURITIES REPRESENTING 1% OR MORE Rule 8.3 of the Takeover Code (the “Code”) 1. KEY INFORMATION (a) Full name of discloser: Barclays PLC. (b) Owner or controller of interests and short positions disclosed, if different from 1(a): The naming of nominee or vehicle companies is insufficient. For a trust, the trustee(s), settlor and beneficiaries must be named.   (c) Nam...
Back to Newsroom